Company Filing History:
Years Active: 2019-2024
Title: Alison E McGonagle: Innovator in Cancer Research
Introduction
Alison E McGonagle is a prominent inventor based in Manchester, GB. She has made significant contributions to the field of cancer research, particularly through her innovative work on PARG inhibitory compounds. With a total of 4 patents to her name, her research focuses on developing new therapeutic options for proliferative disorders.
Latest Patents
Alison's latest patents include groundbreaking work on PARG inhibitory compounds. These compounds function as inhibitors of the PARG (Poly ADP-ribose glycohydrolase) enzyme activity. The invention details compounds of formula I, which are designed to inhibit this enzyme, thereby offering potential treatments for various diseases, including cancer. The patents also encompass processes for the preparation of these compounds and their pharmaceutical compositions.
Career Highlights
Alison E McGonagle is associated with Cancer Research Technology Limited, where she continues to advance her research. Her work is pivotal in the development of new therapies aimed at combating cancer and other conditions linked to PARG activity.
Collaborations
Some of her notable coworkers include Allan Michael Jordan and Colin P Hutton, who collaborate with her in the pursuit of innovative cancer treatments.
Conclusion
Alison E McGonagle's contributions to cancer research through her patents on PARG inhibitory compounds highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.